Stock-Based Compensation (Tables)

9 Months Ended

Jul. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Compensation Arrangements

The compensation cost recognized in the condensed consolidated statements of income for our stock compensation arrangements is as follows:


	Three Months Ended July 31,				Nine Months Ended July 31,
	2025		2024		2025		2024
	(in thousands)
Cost of products	$	22,943	$	14,645	$	66,470	$	44,824
Cost of maintenance and service	10,222		9,677		28,715		28,126
Research and development expense	113,861		89,279		326,274		269,087
Sales and marketing expense	45,564		30,251		117,214		91,811
General and administrative expense	75,133		20,502		117,236		58,702
Stock-based compensation expense from continuing operations before taxes	267,723		164,354		655,909		492,550
Stock-based compensation expense from discontinued operations before taxes	—		17,185		—		47,476
Total stock-based compensation expense before taxes	267,723		181,539		655,909		540,026
Income tax benefit	(38,686)		(29,972)		(94,779)		(89,158)
Stock-based compensation expense after taxes	$	229,037	$	151,567	$	561,130	$	450,868

Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions

The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods are as follows:


	Nine Months Ended July 31,
		2025	2024
Expected life (in years)		2.67 - 2.79	2.89
Risk-free interest rate		3.90% - 4.39%	4.41%
Volatility		33.40% - 34.72%	34.03%
Grant date fair value		$409.94 - $464.17	$600.29

Schedule of Intrinsic Value of Equity Awards Exercised

The intrinsic values of equity awards exercised during the periods are as follows:


	Three Months Ended July 31,				Nine Months Ended July 31,
	2025		2024		2025		2024
	(in thousands)
Intrinsic value of awards exercised	$	31,834	$	90,973	$	86,671	$	166,993

SYNOPSYS INC 10-Q